Sanofi Adr (SNY)

Dec 31, 2025

Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026 - Benzinga

Dec 31, 2025

Dec 30, 2025

Jefferies Maintains Buy on Sanofi (SNY) Despite Regulatory Overhang - Finviz

Dec 30, 2025

Dec 30, 2025

Where is Sanofi (SNY) Headed According to Wall Street? - Finviz

Dec 30, 2025

Dec 29, 2025

Delayed MS Decision and Trial Miss Add to Sanofi's R&D Challenges - Finviz

Dec 29, 2025

Dec 28, 2025

Sanofi (SNY) to Acquire Dynavax Technologies Corporation (DVAX) - Finviz

Dec 28, 2025

Dec 25, 2025

Total debt per share of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView — Track All Markets

Dec 25, 2025

Dec 24, 2025

Why Dynavax Stock Soared Today - Finviz

Dec 24, 2025

Dec 24, 2025

Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise - Finviz

Dec 24, 2025

Dec 24, 2025

Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy - Sahm

Dec 24, 2025

Dec 24, 2025

Our Environmental Impact - Sanofi

Dec 24, 2025

Dec 21, 2025

Bloom Energy Aktie: KI-Boom trifft auf Energiekrise! - Finanztrends

Dec 21, 2025

Dec 17, 2025

Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades - Finviz

Dec 17, 2025

Dec 16, 2025

FOLD Shares Hit 52-Week High: Time to Buy, Sell or Hold the Stock? - Finviz

Dec 16, 2025

Dec 15, 2025

Sanofi (SNY) sees slight pessimism from analysts - MSN

Dec 15, 2025

Dec 15, 2025

Sanofi: Today's Tolebrutinib Setback Shouldn't Worry ShareholdersThis Is Why (SNY) - Seeking Alpha

Dec 15, 2025

Dec 15, 2025

Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration - Sahm

Dec 15, 2025

Dec 15, 2025

Sanofi's Multiple Sclerosis Drug Faces Trial And Regulatory Setbacks - Sahm

Dec 15, 2025

Dec 15, 2025

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025) - ts2.tech

Dec 15, 2025

Dec 14, 2025

SNY Stock Price and Chart — NASDAQ:SNY - TradingView — Track All Markets

Dec 14, 2025

Dec 12, 2025

Sanofi (SNY) Sees Slight Pessimism From Analysts - Finviz

Dec 12, 2025

Dec 10, 2025

JPMorgan Downgrades Sanofi (SNY) to EUR 95 from EUR 105 - Finviz

Dec 10, 2025

Dec 10, 2025

TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia - Finviz

Dec 10, 2025

Dec 10, 2025

Why Wall Street Analysts Are Closely Watching Sanofi (SNY) - Finviz

Dec 10, 2025

Dec 09, 2025

Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play - Finviz

Dec 09, 2025

Dec 09, 2025

KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study - Finviz

Dec 09, 2025

Dec 09, 2025

Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks - Sahm

Dec 09, 2025

Dec 01, 2025

REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? - Finviz

Dec 01, 2025

Nov 28, 2025

Deutsche Bank Maintains a Buy Rating on Sanofi (SNY) - Finviz

Nov 28, 2025

Nov 26, 2025

Kymera Trades Near 52-Week High: Time to Buy, Sell or Hold the Stock? - Finviz

Nov 26, 2025

Nov 25, 2025

SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria - Finviz

Nov 25, 2025

Nov 25, 2025

Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe - Sahm

Nov 25, 2025

Nov 23, 2025

Bloom Energy-Aktie: Vorsicht geboten! - Finanztrends

Nov 23, 2025

Nov 22, 2025

Abbott-Aktie: 21 Milliarden Dollar für neues Wachstum! - Finanztrends

Nov 22, 2025

Nov 21, 2025

Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug - Sahm

Nov 21, 2025

Nov 21, 2025

Wasserstoff-Aktien: Bloom Energy kollabiert erneut, Nel ASA gibt nicht auf und Primary Hydrogen meldet Fortschritte! - Finanztrends

Nov 21, 2025

Nov 21, 2025

A Technical View of the Leifras Co Ltd ADR (LFS) - fostersleader.com

Nov 21, 2025